Evidence map›Paper›PMID 42797639›Full record

ArticleVaccines2026

Trust, Access, and the Division of Responsibility for Vaccine Confidence in Central and Eastern Europe: Paired Own-Country and Regional Ratings from a Multi-Stakeholder Professional Panel.

Teodor Cristian Blidaru, Alexandru Rafila, Diana Nastasă, David Sinclair, Petr Smejkal, Yasmin Maor, Ernest Kuchar, Mariano Votta, Luminița Vâlcea, Valeriu Gheorghiță

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Teodor Cristian BlidaruFaculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu 37, 020021 Bucharest, Romania.ORCID 0009-0007-6776-4709
Alexandru RafilaFaculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu 37, 020021 Bucharest, Romania.
Diana NastasăNational Institute for Health Services Management, Vaselor 31, 021254 Bucharest, Romania.ORCID 0009-0001-0768-5941
David SinclairInternational Longevity Centre UK (ILC-UK), The Foundry, 17 Oval Way, London SE11 5RR, UK.
Petr SmejkalDepartment of Hygiene and Epidemiology, Institute for Clinical and Experimental Medicine (IKEM), Vídeňská 1958/9, 140 21 Prague, Czech Republic.
Yasmin MaorInfectious Disease Unit, E. Wolfson Medical Center, HaLochamim St. 62, Holon 5822012, Israel.ORCID 0000-0001-7258-3434
Ernest KucharDepartment of Paediatrics with Clinical Assessment Unit, Medical University of Warsaw, Żwirki i Wigury 63A, 02-091 Warsaw, Poland.ORCID 0000-0002-7883-2427
Mariano VottaActive Citizenship Network-Cittadinanzattiva, Via Imera 2, 00183 Rome, Italy.ORCID 0000-0001-7557-2546
Luminița VâlceaCOPAC-Coalition of Organisations of Patients with Chronic Diseases in Romania, Str. Țepeș, Vodă 22, 021525 Bucharest, Romania.
Valeriu GheorghițăFaculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Dionisie Lupu 37, 020021 Bucharest, Romania.ORCID 0000-0002-7819-5464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesImmunisation coverage gaps in Central and Eastern Europe (CEE) are commonly attributed to barriers of access. This study measured how the professionals who deliver immunisation services weigh competing barriers, whether their assessments differ when the referent is their own country rather than the CEE region as a whole, and how they rank candidate interventions on expected impact and near-term feasibility.

methodsSixty-two professionals working in twelve countries and at the European level (47 based in CEE, 39 of them in Romania) completed a cross-sectional structured survey around a multi-stakeholder meeting in Bucharest (14 May 2026). Respondents rated 15 barriers twice, for their own country and for the CEE region; rated 16 interventions for the expected impact and 12-24-month feasibility; force-ranked their selections; and assigned the lead responsibility for five system functions.

resultsDigital misinformation was the highest-rated barrier in every subgroup and at both geographic levels. The assessments differed by geographic referent: within respondents, trust and information barriers were rated more severe for their own country and access barriers more severe for the region (d_z = 0.52), a pattern attenuated but retained after standardising within each level; the same regional object was also described differently by respondents inside and outside CEE (d = 1.02). Across the 16 intervention-level means, the expected impact and feasibility were only weakly and imprecisely associated (r = 0.21, 95% CI -0.32 to 0.64), although, within respondents, the two were modestly correlated (r = 0.33). Continuing professional education for primary care ranked first on expected impact and led the forced-choice ranking in every subgroup. The lead responsibility was the clearest for professional training and least settled for equity monitoring.

conclusionsBarriers were assessed differently depending on whether the referent was the respondent's own country or the region as a whole. These are professionals' perceptions, not measured outcomes: access may rank low partly because the panel does not face it personally, and the findings do not place cost and structural determinants second. Regional strategies built on assumptions about neighbouring systems may misallocate attention, and the equity agenda this panel endorses rests on a monitoring function no actor owns.

Indexed as

attitude of health personnelcross-sectional studiesdisinformationhealthcare disparitieshealth policypublic healthrisk perceptionvaccination hesitancy

Identifiers

PMID42797639
PMCPMC13611672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.